Precision Optics Corporation, Inc.POCI

NasdaqHealthcareElectromedical & Electrotherapeutic Apparatus
Price (close)
$4.78
Market cap
$52.3M
P/E
—
Revenue (TTM)
$28.9M
Net income
-$4.9M
Dividend yield
—
1-year total return
8.5%
Net margin
-17.0%
Revenue growth
64.2%
Debt / equity
0.07x

What Precision Optics Corporation, Inc. does.

advanced optical instruments since 1982, and we operate primarily in two key market segments: medical devices and advanced defense/aerospace products. Within our proprietary optical and imaging technology, our unique custom designs, expert manufacturing

capabilities, and advanced engineering and development capabilities have generated traditional endoscopes and endocouplers, digital

imaging endoscopes using CMOS sensor technology, some designed and manufactured for single-use, as well as other, more advanced,

Revenue and profit, by fiscal year.

Fiscal year202020212022202320242025
Revenue$9.9M$10.7M$15.7M$21.0M$19.1M$19.1M
Net income-$1.4M-$102,835-$928,416-$144,613-$3.0M-$5.8M
Free cash flow-$711,642-$29,374-$1.0M-$97,874-$3.0M-$3.8M

More on POCI.

Figures from Precision Optics Corporation, Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.